Download Slide 1

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Følgende foredrag er udlånt med venlig tilladelse af
forfatteren som har alle rettigheder.
Foredraget må kun gengives med tilladelse.
DCS Årsmøde 2011
Renal nerve ablation in the
management of systemic
hypertension
Henning Kelbæk
DSC 2011
History
- Cutting of the great splanchnic nerve (renal denervation)
induced ipsilateral diurese (Bernard 1859)
Electric stimulation of the peripheral cut end (renal
sympathetic stimulation) induced ipsilateral anti-diurese
- Renal denervation is associated with increased renal
blood flow (Starling 1908)
- Renal sympathetic nerve activity:
decreases renal blood flow
increases Renin secretion rate
increases tubular sodium reabsorption
Hypertension
An insidious disease
Background
- Increased SA is common in essential hypertension
- Sympathectomy reduces blood pressure efficiently
- The prevalence of hypertension is appr 10% in DK
- Long-term complications are stroke, MI, renal failure
- In >95% of all cases the hypertension is essential
- In some patients the blood pressure cannot be controlled
despite treatment with 5 different drugs
N Engl J Med 2009:361;9
Renal Nerve Ablation team,
Rigshospitalet
- Cardiology Clinic:
Lia E Bang, Mikael Sander, Jesper Hastrup
Svendsen, Henning Kelbæk
- Nephrology Clinic
Anne-Lise Kamper, Bo Feldt-Rasmussen
Renal Denervation
• Catheter based
transmural ablation
• Disruption of renal
sympathetic nervous
innervation
Symplicity Catheter
• Can be introduced percutaneously into the renal arteries
• Delivers radiofrequency energy
• Can ablate both efferent and afferent renal nerves
Targeting Renal Nerves
• Nerves arise from T10-L2
• The nerves arborize around the artery
and primarily lie within the adventitia
Vessel
Lumen
Media
Adventitia
10
Renal
Nerves
Lancet 2009:373;1275-81
Inclusion criteria:
- BP (office) > 160 on 3 drugs (incl. one diuretic) or
- Intolerance to medication
Exclusion criteria:
Secondary cause of hypertension
GFR < 45 ml/min/1.73m2
Type 1 DM
PM/ICD
Medical treatment (such as warfarin)
Renovascular disease
Lancet 2009;373:1275-81
50 patients (5 excluded due to renal vascular causes)
Office blood pressure prior: 177/101
Mean 4.7 anti-hypertension medications
- 96 % ACEI or AT2A or both
- 76 % betablocker
- 69 % calcium antagonist
- 18 % direct vasodilators
- 96 % diuretics
Lancet 2009;373:1275-81
Trial profile
Lancet 2009;373:1275-81
BP at 1 month: -14/-10
BP at 3 month: -21/-10
BP at 6 month: -22/-11
BP at 12 month: -27/-17
13 % non-responders
Lancet 2009;373:1275-81
Ablation lesions:
4.2 (right) and 3.7 (left Renal Artery)
Pain while energy administration
Mean reduction of renal NA spillover: 47 % (n = 10)
Angiogram (day 14-30; n 18): no stenosis
MRI (6 month; n = 14): no irregularities
1 renal artery dissection (prior to ablation)
1 femoral artery pseudoaneurysm
Lancet 2009;373:1275-81
Case report
Change in kidney NE
N Engl J Med 2009:361;932-4
Case report
Change in whole-body NE
N Engl J Med 2009:361;932-4
Case report
Change in sympathetic activity
N Engl J Med 2009:361;932-4
24 centres: 190 patients screened
106 included:
- 52 renal denervation
- 54 controls
Lancet 2010;376:1903-09
Trial profile
Lancet 2010;376:1903-09
Lancet 2010;376:1903-09
Change in blood pressure
Lancet 2010;376:1903-09
Change in renal function
Lancet 2010;376:1903-09
Data analysers were not masked to treatment assignment
Primary endpoint: Change in seated office-based measurement
of systolic blood pressure at 6 months
Lancet 2010;376:1903-09
Symplicity Catheter
Catheter Tip Features
5mm
Flexible Tip
(self-orienting)
12mm
Deflectable
Shaft
Catheter Handle Features
Deflect tip by pulling lever
towards back of handle
Straighten tip by pushing lever
towards front of handle
Shaft & electrode can rotate independent
from handle body
Renal Angiogram
29
Eligible Anatomy:
• Absence of flow limiting obstructions
• Diameter ≥ 4mm in targeted area
Targeting Renal Nerves
• Treat distal to proximal
• 4-6 focal treatments
• 2 min per treatment
• ≥ 5 mm between locations
• Stable, unique locations
• Circumferential coverage
• Common strategy (dependent on renal
anatomy):
• Distal: Inferior and inferolateral locations
• Proximal: Superior and superolateral locations
• Avoid purely lateral treatments (possible electrode
movement with respiration)
• PULL, ROTATE, ASSESS new location and prior
treatment site
30
Case
20-år gammel HF-elev henvist til renal ablation for hypertension
Disp:
Farmor har hypertension. Ingen med hypertension i ungdommen
Anamnese: Essentiel hypertension siden 11-års-alderen
Problemer med bivirkninger af diverse præpararter
Dårlig medicin compliance
Medicin:
Centyl m/KCl 2.5 mg x 1
Adalat Oros 60 mg x 1
Corodil 20 mg x 1
Objektivt::
Blodtryk 160/100 på begge arme
St.c. & p. : i.a.
Normale femoralispulse
EKG:
i.a.
Patienter med essentiel hypertension
-
hvis blodtryk ikke kan kontrolleres trods
med mindst 3 antihypertensiva
behandling
-
som har uacceptable bivirkninger af den
behandling
medicinske
kan henvises til
Hjertecentrets visitation,
Rigshospitalet
med angivelse af
- Kort anamnese med indikation
- Døgn-blodtryk monitorerings svar
- P-kreatinin
- Medicin liste
Spørgsmål:
Hvad er det sikreste
tegn på forår ?
Spørgsmål:
At pigerne går
Hvad
er sandaler
det sikreste
med
tegn på forår ?